160 related articles for article (PubMed ID: 17310999)
1. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
Bubman D; Guasparri I; Cesarman E
Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
[TBL] [Abstract][Full Text] [Related]
2. The Kaposi's sarcoma-associated herpesvirus LANA protein stabilizes and activates c-Myc.
Liu J; Martin HJ; Liao G; Hayward SD
J Virol; 2007 Oct; 81(19):10451-9. PubMed ID: 17634226
[TBL] [Abstract][Full Text] [Related]
3. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta.
Fujimuro M; Hayward SD
J Virol; 2003 Jul; 77(14):8019-30. PubMed ID: 12829841
[TBL] [Abstract][Full Text] [Related]
4. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency.
Fujimuro M; Wu FY; ApRhys C; Kajumbula H; Young DB; Hayward GS; Hayward SD
Nat Med; 2003 Mar; 9(3):300-6. PubMed ID: 12592400
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus LANA protein downregulates nuclear glycogen synthase kinase 3 activity and consequently blocks differentiation.
Liu J; Martin H; Shamay M; Woodard C; Tang QQ; Hayward SD
J Virol; 2007 May; 81(9):4722-31. PubMed ID: 17314169
[TBL] [Abstract][Full Text] [Related]
6. A Screen for Extracellular Signal-Regulated Kinase-Primed Glycogen Synthase Kinase 3 Substrates Identifies the p53 Inhibitor iASPP.
Woodard C; Liao G; Goodwin CR; Hu J; Xie Z; Dos Reis TF; Newman R; Rho H; Qian J; Zhu H; Hayward SD
J Virol; 2015 Sep; 89(18):9232-41. PubMed ID: 26109723
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the interaction between glycogen synthase kinase 3 and the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen.
Fujimuro M; Liu J; Zhu J; Yokosawa H; Hayward SD
J Virol; 2005 Aug; 79(16):10429-41. PubMed ID: 16051835
[TBL] [Abstract][Full Text] [Related]
8. Physical and functional interactions between STAT3 and Kaposi's sarcoma-associated herpesvirus-encoded LANA.
Muromoto R; Okabe K; Fujimuro M; Sugiyama K; Yokosawa H; Seya T; Matsuda T
FEBS Lett; 2006 Jan; 580(1):93-8. PubMed ID: 16364321
[TBL] [Abstract][Full Text] [Related]
9. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors.
Tolani B; Gopalakrishnan R; Punj V; Matta H; Chaudhary PM
Oncogene; 2014 May; 33(22):2928-37. PubMed ID: 23792448
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus-encoded LANA associates with glucocorticoid receptor and enhances its transcriptional activities.
Togi S; Nakasuji M; Muromoto R; Ikeda O; Okabe K; Kitai Y; Kon S; Oritani K; Matsuda T
Biochem Biophys Res Commun; 2015 Jul; 463(3):395-400. PubMed ID: 26032496
[TBL] [Abstract][Full Text] [Related]
11. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
[TBL] [Abstract][Full Text] [Related]
12. A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia.
Cai Q; Murakami M; Si H; Robertson ES
J Virol; 2007 Oct; 81(19):10413-23. PubMed ID: 17634230
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the interaction between latency-associated nuclear antigen and glycogen synthase kinase 3beta.
Hagen T
J Virol; 2009 Jun; 83(12):6312-7. PubMed ID: 19321622
[TBL] [Abstract][Full Text] [Related]
14. Myc is required for the maintenance of Kaposi's sarcoma-associated herpesvirus latency.
Li X; Chen S; Feng J; Deng H; Sun R
J Virol; 2010 Sep; 84(17):8945-8. PubMed ID: 20573831
[TBL] [Abstract][Full Text] [Related]
15. Human I-mfa domain proteins specifically interact with KSHV LANA and affect its regulation of Wnt signaling-dependent transcription.
Kusano S; Eizuru Y
Biochem Biophys Res Commun; 2010 Jun; 396(3):608-13. PubMed ID: 20417616
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen induces chromosomal instability through inhibition of p53 function.
Si H; Robertson ES
J Virol; 2006 Jan; 80(2):697-709. PubMed ID: 16378973
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53.
Rivas C; Thlick AE; Parravicini C; Moore PS; Chang Y
J Virol; 2001 Jan; 75(1):429-38. PubMed ID: 11119611
[TBL] [Abstract][Full Text] [Related]
19. Distinct p53, p53:LANA, and LANA complexes in Kaposi's Sarcoma--associated Herpesvirus Lymphomas.
Chen W; Hilton IB; Staudt MR; Burd CE; Dittmer DP
J Virol; 2010 Apr; 84(8):3898-908. PubMed ID: 20130056
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of the chromatin binding domain of KSHV LANA.
Woodard C; Shamay M; Liao G; Zhu J; Ng AN; Li R; Newman R; Rho HS; Hu J; Wan J; Qian J; Zhu H; Hayward SD
PLoS Pathog; 2012; 8(10):e1002972. PubMed ID: 23093938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
